Peptide ObservatoryWe bring together reports and research to help you understand the risks and make informed decisions.
Kirby, Fiona and Mel · Corporate leadership, community service and shared experience.
Co-founder & CEO · Conscience IQ
Kirby leads Conscience IQ, bringing together his work in human performance, psychology and neuroscience. Alongside Fiona, he oversees churches through WOWLife and the Apostolic Diocese of Ceylon. His experience spans organizational leadership, community development and public service.
Academic background
MSc, Psychology & Neuroscience — King’s College London.
Co-founder · Conscience IQ
Fiona brings a background in law, organizational development and human performance to Conscience IQ. She co-founded the Warehouse Project and, alongside Kirby, oversees churches through WOWLife. Her experience includes business, creative direction, community development and endurance sport.
Academic background
LLB (Hons) — University of Buckingham.
Master’s in Theology — Fuller Theological Seminary.
Certified High Flow Coach.
Board Director · The Warehouse Project
Mel serves as International Administrative Director of WOW LIFE WORLD and a Board Director of the Warehouse Project. Her experience spans operations, project delivery and community development, including youth education and social empowerment.
Academic background
BSc, Anthropology and Politics — Oxford Brookes University.
Master’s in Global Cultures — King’s College London.
Our wider work spans Conscience IQ, Rapha Ltd and community leadership. Here, we contribute as fellow users and supporters of access to information.
We are peptide users and supporters of better information. We started Peptide Observatory for the sake of others: to make reports, experiences and evidence easier to find and understand.
As users ourselves, we are concerned about how unsafe parts of this industry have become. Unclear product quality, incomplete information and accounts of harm leave people trying to make decisions without a clear picture. We want to be there for those people, helping them see what has been reported and what remains uncertain.
We contribute from our own backgrounds and experience as users. Our support for informed research is not a claim that every peptide or product is safe. Personal experience does not establish clinical safety, and the Observatory does not replace individual medical advice.
The USD 2.99 monthly membership fee is intended to cover retrieving information and the costs of hosting, maintenance and keeping the site running. Our purpose is to help others access information about reported benefits, harms and uncertainties.
Membership payments are not open yet. You can register your interest without being charged.
Monthly chart: confirmed 2026 publication dates. Peptide chart: all indexed reports by default.
13 total source records = 2 dated 2026 + 4 from earlier years + 7 with unresolved dates. All are included in the default peptide chart; only dated 2026 records can be placed on the monthly chart.
2026 reports by publication month
0 = no dated report in this collection, not no incidents. The current month is partial; future months are outside the collection period.
All dates, including unresolved dates · 13 source records
Y-axis · Anecdotal incident reports
X-axis · Peptides
Most named: MOTS-C (5 each). A combination report counts once in the monthly total and once for each named peptide. This does not identify which compound caused the event or rank danger.
13 source records · independent clinical verification
No independent clinical verification documented · 13
Independently clinically verified · 0
The collection currently contains no documented independent clinical verification. Reading a source, reviewing a submission or automatically screening text does not confirm diagnosis or causation. All reports remain included in the peptide chart.
Every source record appears once here, including reports that cannot be assigned to a month.
Dated 2026 · 2
Earlier years · 4
Date unresolved · 7
Itchy palms, diarrhoea, shakiness and increased heart rate; breathing difficulty explicitly denied. Author reported resolution within an hour.
PO-S001 · Reddit · Event date: “Today” in post; timezone not establishedHives, itching and throat tightening after combined exposure. Emergency-room attendance reported.
PO-S002 · Reddit · Event date: “Today” in post; timezone not establishedAuthor reports anaphylaxis and posts an image described as a tryptase result. Emergency-room visit reported.
PO-S003 · Reddit · Event date: Before this follow-up post; exact event date unknownBreathing difficulty, tongue swelling, welts and rapid heart rate. Emergency treatment including epinephrine and oxygen reported.
PO-S004 · Reddit · Event date: “Last night” in post; local calendar date unknownFlushing, intense itching and widespread welts after restarting a combination. Emergency-room treatment for a severe allergic reaction reported.
PO-S005 · Reddit · Event date: UnknownCommenter describes a similar reaction with nausea and difficulty breathing. Not reported.
PO-S006 · Reddit · Event date: “Today” in comment; exact date unknownPersistent injection-site itching progressed to itchy palms and burning with later injections. Stopped treatment; reported little perceived benefit.
PO-S007 · ExcelMale · Event date: Symptoms described over preceding monthsPounding heart, flushing, welts and itching after months of use. Reported symptoms subsided after about 20 minutes.
PO-S008 · ExcelMale · Event date: “Last night” in comment; exact local date not establishedAuthor reports severe tongue/throat swelling and breathing difficulty after combined exposure. Ambulance care and four epinephrine injections reported.
PO-S009 · Instagram · Event date: Before upload; exact date not establishedCommenter reports hallucinations and a blood-pressure drop. Not reported.
PO-S010 · Instagram · Event date: UnknownCommenter describes a bad reaction; specific symptoms not supplied. Not reported.
PO-S011 · Instagram · Event date: UnknownCommenter reports a similar experience with a tesamorelin/ipamorelin mixture. Not reported.
PO-S012 · Instagram · Event date: UnknownAuthor reports hives, low blood pressure, fainting, sweating and increased pulse. About 45 minutes of symptoms reported; no emergency treatment stated.
PO-S013 · Facebook · Event date: “Last night” in post; exact date unknownAnecdotal, selected public posts and comments; clinical diagnosis and causality unverified. These are report counts, not incidence rates or unique patient counts. Publication month may differ from event month. Reports with missing or conflicting dates are included in the all-dates peptide chart and source register, but excluded from the monthly chart. Counts across peptides can exceed the source-record total because a report may name more than one peptide.
Built around traceable evidence. 13 public posts and comments are indexed alongside FDA sources. See Sources & coverage for automated collection status.
Initial collection plus reviewed and automatically screened imports
7 comments + 6 original posts. Selected for adverse-event content; not a representative sample, incidence rate or confirmed case count.
Initial collection access limits are documented under Sources & coverage.
Anaphylaxis, collapse and serious biological hazards need clinical assessment, not a forum consensus.
If someone has trouble breathing or collapses, contact local emergency services immediately. Do not wait for a report review.
Source-read accounts. People, diagnosis and product identity remain unverified.
Dates refer to the original post or comment, not necessarily the event. 7 records have missing or conflicting publication dates and are excluded when a date range is applied. The initial collection was made on 2026-09-12; reviewed automated imports are added separately.
| Record / source | Posted date | Reported exposure | Symptoms / outcome | Actual lot | |
|---|---|---|---|---|---|
| PO-S001Reddit · Post | 30 Dec 2023 | MOTS-C5 mg | Itchy palms, diarrhoea, shakiness and increased heart rate; breathing difficulty explicitly denied. Author reported resolution within an hour. | Unknown | |
| PO-S002Reddit · Post | 16 Feb 2026 | MOTS-C + SS-31MOTS-C 3 mg + SS-31 10 mg | Hives, itching and throat tightening after combined exposure. Emergency-room attendance reported. | Unknown | |
| PO-S003Reddit · Post | 22 May 2026 | Retatrutide0.5 mg | Author reports anaphylaxis and posts an image described as a tryptase result. Emergency-room visit reported. | Unknown | |
| PO-S004Reddit · Post | 20 Nov 2024 | CJC-1295 + IpamorelinNot stated in original post | Breathing difficulty, tongue swelling, welts and rapid heart rate. Emergency treatment including epinephrine and oxygen reported. | Unknown | |
| PO-S005Reddit · Comment | Exact comment date unavailable | CJC-1295 + IpamorelinCJC no DAC 200 mcg + ipamorelin 200 mcg | Flushing, intense itching and widespread welts after restarting a combination. Emergency-room treatment for a severe allergic reaction reported. | Unknown | |
| PO-S006Reddit · Comment | Exact comment date unavailable | MOTS-C5 mg | Commenter describes a similar reaction with nausea and difficulty breathing. Not reported. | Unknown | |
| PO-S007ExcelMale · Comment | 6 Jun 2017 | SermorelinNot stated | Persistent injection-site itching progressed to itchy palms and burning with later injections. Stopped treatment; reported little perceived benefit. | Unknown | |
| PO-S008ExcelMale · Comment | 28 May 2019 | IpamorelinNot stated | Pounding heart, flushing, welts and itching after months of use. Reported symptoms subsided after about 20 minutes. | Unknown | |
| PO-S009Instagram · Post | 23–24 Jul 2026 · date conflict | MOTS-C + KLOWNot stated | Author reports severe tongue/throat swelling and breathing difficulty after combined exposure. Ambulance care and four epinephrine injections reported. | Unknown | |
| PO-S010Instagram · Comment | Comment date unavailable | OxytocinNot stated | Commenter reports hallucinations and a blood-pressure drop. Not reported. | Unknown | |
| PO-S011Instagram · Comment | Comment date unavailable | Tesamorelin + MOTS-CNot stated | Commenter describes a bad reaction; specific symptoms not supplied. Not reported. | Unknown | |
| PO-S012Instagram · Comment | Comment date unavailable | Tesamorelin + IpamorelinNot stated | Commenter reports a similar experience with a tesamorelin/ipamorelin mixture. Not reported. | Unknown | |
| PO-S013Facebook · Post | Publication date unverified | Tesamorelin + CJC-1295Not stated | Author reports hives, low blood pressure, fainting, sweating and increased pulse. About 45 minutes of symptoms reported; no emergency treatment stated. | Unknown |
What the sources say. What remains unknown.
| Peptide | Evidence signal | Primary concern | Public accounts | FDA reports¹ | |
|---|---|---|---|---|---|
| Regulatory safety signal | Dosing errors · gastrointestinal events | 990 | |||
| Regulatory safety signal | Dose escalation · product authenticity | >730 | |||
| Safety evidence limited | Immune response · purity uncertainty | — | |||
| Regulatory safety signal | Increased heart rate · vasodilation | — | |||
| Safety evidence limited | Immune response · uncertain causality | — | |||
| Unapproved product concern | Unapproved online products | — | |||
| Anecdotal · unverified | Public self-report · causality unresolved | — | |||
| Anecdotal · unverified | Public self-report · causality unresolved | — | |||
| Anecdotal · unverified | Public self-report · causality unresolved | — | |||
| Anecdotal · unverified | Public self-report · causality unresolved | — | |||
| Anecdotal · unverified | Public self-report · causality unresolved | — | |||
| Anecdotal · unverified | Public self-report · causality unresolved | — | |||
| Anecdotal · unverified | Public self-report · causality unresolved | — |